Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Change in Account Payables (2016 - 2025)

Healthstream (HSTM) has disclosed Change in Account Payables for 16 consecutive years, with -$48000.0 as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 92.42% to -$48000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $405000.0 through Dec 2025, down 36.02% year-over-year, with the annual reading at $405000.0 for FY2025, 36.02% down from the prior year.
  • Change in Account Payables for Q4 2025 was -$48000.0 at Healthstream, down from $819000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $1.9 million in Q1 2022, with the low at -$2.5 million in Q2 2021.
  • Average Change in Account Payables over 5 years is -$160750.0, with a median of -$166000.0 recorded in 2021.
  • The sharpest move saw Change in Account Payables surged 715.41% in 2022, then crashed 1289.16% in 2023.
  • Over 5 years, Change in Account Payables stood at -$166000.0 in 2021, then changed by 0.0% to -$166000.0 in 2022, then plummeted by 1289.16% to -$2.3 million in 2023, then skyrocketed by 72.55% to -$633000.0 in 2024, then soared by 92.42% to -$48000.0 in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$48000.0, $819000.0, and -$791000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.